Loading...
Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
AIM OF THE STUDY: Podocalyxin-like 1 is a transmembrane glyco-protein whose overexpression associates in many cancers with poor prognosis and unfavorable clinicopathological characteristics. Until now, its prognostic value has never been studied in pancreatic ductal adenocarcinoma (PDAC). The aim of...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4459962/ https://ncbi.nlm.nih.gov/pubmed/26053486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0129012 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|